New Results
CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to Cetuximab
Roberto Arriga, Sara Caratelli, Giulia Lanzilli, Alessio Ottaviani, Carlo Cenciarelli, Tommaso Sconocchia, Giulio Cesare Spagnoli, Giandomenica Iezzi, Mario Roselli, Davide Lauro, Gianpietro Dotti, Soldano Ferrone, Giuseppe Sconocchia
doi: https://doi.org/10.1101/588525
Roberto Arriga
1Department of Systems Medicine, Endocrinology and Medical Oncology, University of Rome “Tor Vergata”, Rome, Italy
Sara Caratelli
2Institute of Translational Pharmacology, CNR, Rome, Italy
Giulia Lanzilli
2Institute of Translational Pharmacology, CNR, Rome, Italy
Alessio Ottaviani
2Institute of Translational Pharmacology, CNR, Rome, Italy
Carlo Cenciarelli
2Institute of Translational Pharmacology, CNR, Rome, Italy
Tommaso Sconocchia
3Otto Loewi Research Center, Chair of Immunology and Pathophysiology Medical University of Graz, Graz, Austria
Giulio Cesare Spagnoli
2Institute of Translational Pharmacology, CNR, Rome, Italy
Giandomenica Iezzi
4Department of Surgery, Ente Ospedaliero Cantonale, Università della Svizzera Italiana, Lugano, Switzerland
Mario Roselli
1Department of Systems Medicine, Endocrinology and Medical Oncology, University of Rome “Tor Vergata”, Rome, Italy
Davide Lauro
1Department of Systems Medicine, Endocrinology and Medical Oncology, University of Rome “Tor Vergata”, Rome, Italy
Gianpietro Dotti
5Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA
Soldano Ferrone
6Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Giuseppe Sconocchia
2Institute of Translational Pharmacology, CNR, Rome, Italy
Article usage
Posted March 26, 2019.
CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to Cetuximab
Roberto Arriga, Sara Caratelli, Giulia Lanzilli, Alessio Ottaviani, Carlo Cenciarelli, Tommaso Sconocchia, Giulio Cesare Spagnoli, Giandomenica Iezzi, Mario Roselli, Davide Lauro, Gianpietro Dotti, Soldano Ferrone, Giuseppe Sconocchia
bioRxiv 588525; doi: https://doi.org/10.1101/588525
CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to Cetuximab
Roberto Arriga, Sara Caratelli, Giulia Lanzilli, Alessio Ottaviani, Carlo Cenciarelli, Tommaso Sconocchia, Giulio Cesare Spagnoli, Giandomenica Iezzi, Mario Roselli, Davide Lauro, Gianpietro Dotti, Soldano Ferrone, Giuseppe Sconocchia
bioRxiv 588525; doi: https://doi.org/10.1101/588525
Subject Area
Subject Areas
- Biochemistry (11574)
- Bioengineering (8626)
- Bioinformatics (28876)
- Biophysics (14809)
- Cancer Biology (11945)
- Cell Biology (17175)
- Clinical Trials (138)
- Developmental Biology (9309)
- Ecology (14023)
- Epidemiology (2067)
- Evolutionary Biology (18130)
- Genetics (12148)
- Genomics (16621)
- Immunology (11712)
- Microbiology (27705)
- Molecular Biology (11402)
- Neuroscience (60109)
- Paleontology (448)
- Pathology (1849)
- Pharmacology and Toxicology (3185)
- Physiology (4878)
- Plant Biology (10279)
- Synthetic Biology (2850)
- Systems Biology (7291)
- Zoology (1619)